SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001047469-16-016832
Filing Date
2016-11-18
Accepted
2016-11-18 16:30:50
Documents
13

Document Format Files

Seq Description Document Type Size
1 424B4 a2230344z424b4.htm 424B4 1205683
2 G340062.JPG g340062.jpg GRAPHIC 11597
3 G844311.JPG g844311.jpg GRAPHIC 81809
4 G417499.JPG g417499.jpg GRAPHIC 67167
5 G401145.JPG g401145.jpg GRAPHIC 125123
6 G795922.JPG g795922.jpg GRAPHIC 105159
7 G417734.JPG g417734.jpg GRAPHIC 113535
8 G976432.JPG g976432.jpg GRAPHIC 89219
9 G431429.JPG g431429.jpg GRAPHIC 92163
10 G665843.JPG g665843.jpg GRAPHIC 143249
11 G878511.JPG g878511.jpg GRAPHIC 47371
12 G952131.JPG g952131.jpg GRAPHIC 1224
13 G413503.JPG g413503.jpg GRAPHIC 15691
  Complete submission text file 0001047469-16-016832.txt   2438850
Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-214540 | Film No.: 162008100
SIC: 2834 Pharmaceutical Preparations